Site Selection Challenges in Emerging Markets for Clinical Trials
Navigating Site Selection Challenges in Emerging Markets for Clinical Trials Emerging markets—such as parts of Asia, Africa, Latin America, and Eastern Europe—are becoming increasingly attractive for clinical trial conduct. These regions offer large treatment-naïve populations, reduced costs, and diverse disease prevalence. However, site selection in emerging markets comes with its own set of logistical, regulatory,…
Read More “Site Selection Challenges in Emerging Markets for Clinical Trials” »